These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21736752)

  • 1. In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.
    Tsoupras AB; Chini M; Tsogas N; Lioni A; Tsekes G; Demopoulos CA; Lazanas MC
    J Inflamm (Lond); 2011 Jul; 8():17. PubMed ID: 21736752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?
    Tsoupras AB; Chini M; Tsogas N; Fragopoulou E; Nomikos T; Lioni A; Mangafas N; Demopoulos CA; Antonopoulou S; Lazanas MC
    AIDS Res Hum Retroviruses; 2008 Aug; 24(8):1079-86. PubMed ID: 18620493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
    Verouti SN; Tsoupras AB; Alevizopoulou F; Demopoulos CA; Iatrou C
    Int J Artif Organs; 2013 Feb; 36(2):87-96. PubMed ID: 23335378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor levels and metabolism in Tangier disease: a case study.
    Kolovou V; Papakonstantinou VD; Stamatakis G; Verouti SN; Xanthopoulou MN; Kolovou G; Demopoulos CA
    Lipids Health Dis; 2012 Jul; 11():89. PubMed ID: 22769014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial.
    Gavriil L; Detopoulou M; Petsini F; Antonopoulou S; Fragopoulou E
    Br J Nutr; 2019 May; 121(9):982-991. PubMed ID: 30940217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.
    Margariti A; Papakonstantinou VD; Stamatakis GM; Demopoulos CA; Machalia C; Emmanouilidou E; Schnakenburg G; Nika MC; Thomaidis NS; Philippopoulos AI
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration.
    Moschos MM; Chatziralli IP; Stamatakis G; Papakonstantinou VD; Demopoulos CA
    Cutan Ocul Toxicol; 2014 Sep; 33(3):235-41. PubMed ID: 24147947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its Metabolism.
    Moschos MM; Chatziralli IP; Stamatakis G; Papakonstantinou VD; Tsatsos M; Demopoulos CA
    Semin Ophthalmol; 2017; 32(2):198-203. PubMed ID: 26270771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
    Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
    Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
    Schuster DP; Metzler M; Opal S; Lowry S; Balk R; Abraham E; Levy H; Slotman G; Coyne E; Souza S; Pribble J;
    Crit Care Med; 2003 Jun; 31(6):1612-9. PubMed ID: 12794395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(
    Kalampalidis A; Damati A; Matthopoulos D; Tsoupras AB; Demopoulos CA; Schnakenburg G; Philippopoulos AI
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz HAART regimen.
    Chini M; Tsoupras AB; Mangafas N; Tsogas N; Papakonstantinou VD; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
    Int J Immunopathol Pharmacol; 2012; 25(1):247-58. PubMed ID: 22507337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
    Nunez D; Kumar R; Hanahan DJ
    Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen.
    Chini M; Tsoupras AB; Mangafas N; Tsogas N; Papakonstantinou VD; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):766-75. PubMed ID: 22050695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells.
    Xanthopoulou MN; Asimakopoulos D; Antonopoulou S; Demopoulos CA; Fragopoulou E
    Food Chem; 2014 Dec; 165():50-9. PubMed ID: 25038648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
    Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
    Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.
    Hogaboam CM; Donigi-Gale D; Shoupe TS; Bissonnette EY; Befus AD; Wallace JL
    Br J Pharmacol; 1992 Jan; 105(1):87-92. PubMed ID: 1596692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
    Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
    Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.